Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of oral linaclotide in children with functional constipation
2019-001500-38Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Apr 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in functional constipation (FC) and constipation comparing Linaclotide with Placebo (2 arms). Primary endpoint: Change from baseline in 12-week SBM frequency rate. Started Apr 2020; status: completed.
02
Drugs
linaclotide
03
Conditions
functional constipation (FC)constipation
Beyond the preview
Go deeper on 2019-001500-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001500-38.